UK Accuses Actavis Of Inking Deals To Prop Up Drug Prices
The U.K.'s antitrust regulator on Friday alleged that Actavis signed illegal agreements with a rival to forestall competition and allow the drugmaker to sustain excessive pricing for hydrocortisone tablets charged to...To view the full article, register now.
Already a subscriber? Click here to view full article